Lv64
1780 积分 2024-04-07 加入
Artificial intelligence in drug discovery — what it is, where we stand and the path forward
2天前
已完结
Organoid analytical toolkits
5天前
已完结
Introduction to the 3RsC's cross-platform microphysiological systems evaluation for drug-induced liver injury in collaboration with FDA-CDER
9天前
已完结
AI-powered methods shake up animal testing
15天前
已完结
Brain-shuttle biologics chart new paths across the blood–brain barrier
26天前
已完结
Automated stem cell-derived organoid platforms for disease modeling
1个月前
已完结
Frontier AI companies as biotech acquirers
1个月前
已完结
DILI-Context: A Dose- and Exposure-Enriched Knowledge Base for Translational Liver Safety Assessment
1个月前
已完结
Influence of basal media composition on barrier fidelity within human pluripotent stem cell‐derived blood‐brain barrier models
1个月前
已完结
Immune-competent new approach methodologies for a hybrid future
2个月前
已完结
皖公网安备34019202002308
